Polyamides based on aminoalkylpiperazine or aminoarylpiperazine for hot-melt adhesives

US10550227B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10550227-B2
Application numberUS-201515322934-A
CountryUS
Kind codeB2
Filing dateJun 22, 2015
Priority dateJul 1, 2014
Publication dateFeb 4, 2020
Grant dateFeb 4, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A semi-crystalline polyamide including at least one monomer resulting from the condensation of a diacid and of a diamine of formula AP.Y, the semi-crystalline polyamide having the following general formula (I): AP.Y/(A)m/(Pip.Y′)n/(B.Y″)q and the semi-crystalline polyamide having an Mp1 less than or equal to approximately 150° C., in particular less than or equal to approximately 130° C., in particular less than or equal to approximately 120° C. and/or a Tg less than or equal to approximately 60° C., in particular less than or equal to approximately 50° C., in particular less than or equal to approximately 40° C., as determined respectively by DSC according to standard ISO 11357-3 (2013) and ISO 11357-2 (2013).

First claim

Opening claim text (preview).

The invention claimed is: 1. A semicrystalline polyamide comprising at least one monomer resulting from the condensation of a diacid and a diamine of formula AP.Y, wherein: AP represents at least one asymmetric diamine monomer of the piperazine type with the following formula: wherein: R 1 represents H or —Z 1 —NH 2 and Z 1 represents an alkyl, a cycloalkyl or an aryl having up to 15 carbon atoms, R 2 represents H or —Z 2 —NH 2 and Z 2 represents an alkyl, a cycloalkyl or an aryl having up to 15 carbon atoms, R 1 and R 2 being different from one another, and Y represents at least one dicarboxylic acid excluding the dimers and/or trimers of fatty acids, said semicrystalline polyamide having the following general formula (IV): AP.Y/Pip.Y′ wherein: A represents at least one polyamide with a long-chain aliphatic unit, excluding PA6, Pip denotes piperazine and Y′ represents at least one dicarboxylic acid excluding the dimers and/or trimers of fatty acids, and Y and Y′ may be identical or different, Y″ represents at least one dicarboxylic acid excluding the dimers and/or trimers of fatty acids, and Y″ may be identical to or different from Y and/or Y′ and said semicrystalline polyamide has a Tm 1 less than or equal to about 150° C., and/or a Tg less than or equal to about 40° C., as determined by DSC according to standard ISO 11357-3 (2013) and ISO 11357-2 (2013), respectively, and a solubility in an alcohol-water mixture, in particular an isopropanol-water mixture (85/15: v/v) at room temperature (20° C.) of at least 15%, and the AP.Y/Pip.Y′ weight ratio is from 40/60 to 99/1. 2. The semicrystalline polyamide according to claim 1 , wherein AP represents aminoethylpiperazine (AEP) and Y=Y′ is selected from adipic acid, sebacic acid, azelaic acid, dodecanedioic acid, brassylic acid, tetradecanedioic acid, hexanedioic acid and octadecanedioic acid. 3. The semicrystalline polyamide according to claim 1 , wherein said polyamide is selected from AEP.10/Pip.10 and AEP 12/Pip.12. 4. The semicrystalline polyamide according to claim 1 , said polyamide having a Tm 1 less than or equal to about 100° C. and/or a Tg less than or equal to about 35° C. 5. The semicrystalline polyamide according to claim 1 , wherein the Y/Y′ molar ratio is from 15/85 to 85/15. 6. The semicrystalline polyimide according to claim 1 , wherein AP represents aminoethylpiperazine (AEP) and Y and Y′ are selected from adipic acid, sebacic acid, azelaic acid, dodecanedioic acid, brassylic acid, tetradecanedioic acid, hexanedioic acid and octadecanedioic acid.

Assignees

Inventors

Classifications

  • Polyamides derived from polyamines and polycarboxylic acids (C09J177/10 takes precedence) · CPC title

  • Polyamides derived from polyamines and polycarboxylic acids (C08L77/10 takes precedence) · CPC title

  • with only two nitrogen atoms in the ring · CPC title

  • derived from amino acids, polyamines and polycarboxylic acids · CPC title

  • Polyamides containing oxygen in the form of ether groups (C08G69/12, C08G69/32 take precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10550227B2 cover?
A semi-crystalline polyamide including at least one monomer resulting from the condensation of a diacid and of a diamine of formula AP.Y, the semi-crystalline polyamide having the following general formula (I): AP.Y/(A)m/(Pip.Y′)n/(B.Y″)q and the semi-crystalline polyamide having an Mp1 less than or equal to approximately 150° C., in particular less than or equal to approximately 130° C., in pa…
Who is the assignee on this patent?
Arkema France
What technology area does this patent fall under?
Primary CPC classification C08G69/265. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).